NCT07526857已完成不适用
Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy: A12 Month Multimodal Imaging Study
Federico II University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年1月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Epivascular glia regression
研究概览
简要总结
The aim of the study is to evaluate in diabetic patients affected by diabetic retinopathy epivascular glia regression and macular pigment restoration after faricimab injection in diabetic retinopathy in a 1 year follow up
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •diagnosis of diabetic macular edema, diabetic retinopathy
排除标准
- •previous ocular surgery, history of vitreoretinal and/or retinal vascular diseases, uveitis, myopia over 6 dioptres, significant corneal and/or lens opacity, glaucoma, ocular MNV related to other causes than nAMD, geographic atrophy, subretinal fibrosis, previous treatments for MNV
研究组 & 干预措施
Diabetic macular edema treated with Eylea 2 mg
Diabetic macular edema treated with Eylea 2 mg
干预措施: Aflibercept (2.0 mg) (Drug)
Diabetic macular edema treated with Faricimab
干预措施: Faricimab Injection [Vabysmo] (Drug)
结局指标
主要结局
Epivascular glia regression
时间窗: From January 2025 to January 2026
Epivascular glia regression
Macular pigment changes
时间窗: From January 2025 to January 2026
Macular pigment changes
次要结局
未报告次要终点
研究者
Gilda Cennamo
GCennamo
Federico II University
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Impact of diabetic retinopathy and neuropathy on cognition, visual perception, retinal microvasculature and neuroinflammatory biomarker in type II diabetes mellitusCTRI/2024/10/076002Ms Preethi Naik168
尚未招募
不适用
Observational study to evaluate the effects of laser on accommodation, pupil size and contrast sensitivityCTRI/2025/07/091369Sankara eye hospital, Shivamogga50
Unknown
不适用
ELABELA 与糖尿病视网膜病变的相关性研究ChiCTR21000546392018 年院重点人才项目
尚未招募
Phase 3 4
Study on the effect of ayurvedic medicine and therapy in diabetic retinopathyCTRI/2024/04/065524Dr BRKR Government Ayurvedic Medical College30
Unknown
不适用
刘茹冰医师：该研究尚未获得伦理委员会批准。请于批准后再开始纳入参试者，并与我们联系上传批件。 糖尿病相关保护因子对糖尿病视网膜病变的作用及机制研究糖尿病视网膜病变ChiCTR1900025943项目基金100